RCT to Compare Orlistat and Polyglucosamine for the Management of Overweight and Obesity

• Status: Completed
• Trial end date: 2013-08-01
• Target enrollment: 0
• Participant gender: All

Summary

This trial compares two treatment methods:

1. Orlistat 60 mg to be taken three times daily one capsule; indicated for weight loss in overweight adults. Important is also that it is taken along with a reduced-calorie and low-fat diet.

2. Polyglucosamine tablets to be taken two times daily two tablets, taken with the two main meals with the highest fat content, indicated for weight maintenance and weight loss.

• Phase: N/A
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Certmedica International GmbH
• Treatments: Orlistat

Criteria

Inclusion Criteria:

• BMI ≥ 28 kg/m² and < 45 kg/m²

• Waist circumference > 80 cm (women) > 94 cm (men)

Exclusion Criteria:

• Energy intake lower than the standard value according to Miffin St-Jeor equation

• Pregnancy or breast-feeding

• Addiction to alcohol

• Inability to fulfil the requirement of the trial protocol

• Cancer ,malignant tumour

• Hypersensitivity reactions to crustaceans or ingredient of the study medication

• Chronic diseases not under control with adequate therapy

• Diabetes